WINTON GROUP Ltd reduced its holdings in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 88.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,732 shares of the biotechnology company’s stock after selling 192,453 shares during the quarter. WINTON GROUP Ltd’s holdings in […]